To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

NCT02459795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

469

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Ingenol Mebutate (Perrigo)
DRUG: Ingenol Mebutate (Reference)
DRUG: Placebo gel

Sponsor

Padagis LLC